Live Salesforce, Inc. Vote →

Never Miss Important Company Updates Again

Get AI-powered summaries of SEC filings delivered to your inbox

Follow your favorite stocks and get email alerts when they release important updates. Completely free.

Covers 5,000+ public companies
Get started →
Sign up to stay up to date with the stocks you care about
Follow biote Corp.

Get SEC filing alerts via email and in your feed for biote Corp.

BTMD

biote Corp.

About biote Corp.

Biote Corp. provides a practice-building platform for healthcare practitioners specializing in hormone optimization, primarily through education, certification, practice management software, and proprietary clinical tools. It offers bioidentical hormone therapies, including pellets and topical formulations, along with a line of dietary supplements targeting aging populations. Serving a large, growing market, the company emphasizes practitioner training, brand recognition, and a scalable, fee-based revenue model.
This description was generated via AI from an annual report. Updated 8 months ago.

Latest SEC Filings from biote Corp.

1
1
biote Corp. Biote Corp. Reports 8.3% Revenue Decline and Significant Net Income Drop in Q1 2026

Via official filing (AI summary) | 24 days ago | 0 comments

2
1
biote Corp. Biote Corp. Reports $192.2 Million Revenue and $31.6 Million Net Income for Fiscal Year 2025

Via official filing (AI summary) | 3 months ago | 0 comments

3
1
biote Corp. Biote Corp. Reports $47.96 Million Revenue in Q3 2025, Down 6.7% Year-Over-Year

Via official filing (AI summary) | 7 months ago | 0 comments

4
1
biote Corp. Biote Corp. Reports Q2 2025 Revenue of $48.9 Million, Net Income Turnaround

Via official filing (AI summary) | 10 months ago | 0 comments

5
1
biote Corp. Biote Corp. Reports $48.99 Million Revenue in Q1 2025, Achieving 4.7% Growth

Via official filing (AI summary) | about 1 year ago | 0 comments

6
1
biote Corp. Biote Corp. Reports $197.2 Million Revenue for 2024, Achieves Net Income of $0.05 Million

Via official filing (AI summary) | about 1 year ago | 0 comments

7
1
biote Corp. Biote Corp. Reports 12.8% Revenue Growth, Net Income Decline in Q3 2024

Via official filing (AI summary) | over 1 year ago | 0 comments